FR2253512A1 - - Google Patents

Info

Publication number
FR2253512A1
FR2253512A1 FR7439371A FR7439371A FR2253512A1 FR 2253512 A1 FR2253512 A1 FR 2253512A1 FR 7439371 A FR7439371 A FR 7439371A FR 7439371 A FR7439371 A FR 7439371A FR 2253512 A1 FR2253512 A1 FR 2253512A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7439371A
Other languages
French (fr)
Other versions
FR2253512B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of FR2253512A1 publication Critical patent/FR2253512A1/fr
Application granted granted Critical
Publication of FR2253512B1 publication Critical patent/FR2253512B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
FR7439371A 1973-11-30 1974-12-02 Expired FR2253512B1 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (2)

Publication Number Publication Date
FR2253512A1 true FR2253512A1 (enExample) 1975-07-04
FR2253512B1 FR2253512B1 (enExample) 1978-02-03

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7439371A Expired FR2253512B1 (enExample) 1973-11-30 1974-12-02

Country Status (14)

Country Link
US (1) US4045574A (enExample)
JP (1) JPS5084561A (enExample)
AT (1) AT347611B (enExample)
CA (1) CA1030522A (enExample)
CH (1) CH618183A5 (enExample)
DD (1) DD115659A5 (enExample)
DK (1) DK134348C (enExample)
ES (1) ES432106A1 (enExample)
FR (1) FR2253512B1 (enExample)
GB (1) GB1494097A (enExample)
IE (1) IE40423B1 (enExample)
IL (1) IL46153A (enExample)
NL (1) NL7415577A (enExample)
SE (1) SE408426B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
WO2004016640A2 (en) * 2002-08-16 2004-02-26 Pharmacia & Upjohn Company Llc 5 ANDROSTEN-3β-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
US9512165B2 (en) 2013-04-17 2016-12-06 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
ES2998982T3 (en) 2013-04-17 2025-02-24 Sage Therapeutics Inc 19-nor neuroactive steroids for inducing sedation
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
PT3021852T (pt) 2013-07-19 2021-04-21 Sage Therapeutics Inc Esteroides neuroativos, composições e utilizações das mesmas
CN105579043B (zh) 2013-08-23 2021-09-14 萨奇治疗股份有限公司 神经活性类固醇、组合物和其用途
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
RS60642B1 (sr) 2014-10-16 2020-09-30 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
WO2016061527A1 (en) 2014-10-16 2016-04-21 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
HUE049014T2 (hu) 2014-11-27 2020-09-28 Sage Therapeutics Inc Készítmények és módszerek a központi idegrendszer rendellenességeinek kezelésére
SI3250210T1 (sl) 2015-01-26 2021-07-30 Sage Therapeutics, Inc. Sestavki in metode za zdravljenje CNS motenj
WO2016134301A2 (en) 2015-02-20 2016-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2017296295B2 (en) 2016-07-11 2022-02-24 Sage Therapeutics, Inc. C7, C12, and C16 substituted neuroactive steroids and their methods of use
NZ749664A (en) 2016-07-11 2025-08-29 Sage Therapeutics Inc C17, c20, and c21 substituted neuroactive steroids and their methods of use
CN111741965B (zh) * 2017-12-22 2024-06-25 萨奇治疗股份有限公司 治疗中枢神经系统疾病的组合物和方法
CN113383004A (zh) 2018-12-05 2021-09-10 萨奇治疗股份有限公司 神经活性类固醇及其使用方法
JP7592600B2 (ja) 2019-01-08 2024-12-02 成都康弘薬業集団股▲フン▼有限公司 ステロイド化合物、その使用、およびその調製方法
KR20220016098A (ko) 2019-05-31 2022-02-08 세이지 테라퓨틱스, 인크. 신경활성 스테로이드 및 이의 조성물
JP7670632B2 (ja) * 2019-06-27 2025-04-30 セージ セラピューティクス, インコーポレイテッド Cns障害を治療するための組成物及び方法
CN114787174A (zh) * 2019-06-27 2022-07-22 萨奇治疗股份有限公司 用于治疗cns病症的组合物和方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
IE40423B1 (en) 1979-05-23
GB1494097A (en) 1977-12-07
DD115659A5 (enExample) 1975-10-12
NL7415577A (nl) 1975-06-03
IL46153A0 (en) 1975-02-10
AU7586774A (en) 1976-06-03
AT347611B (de) 1979-01-10
JPS5084561A (enExample) 1975-07-08
ES432106A1 (es) 1976-11-01
IE40423L (en) 1975-05-30
ATA950774A (de) 1978-05-15
IL46153A (en) 1979-01-31
DK134348C (da) 1977-03-21
CA1030522A (en) 1978-05-02
SE7414960L (enExample) 1975-06-02
CH618183A5 (enExample) 1980-07-15
DK134348B (da) 1976-10-25
US4045574A (en) 1977-08-30
SE408426B (sv) 1979-06-11
DK604174A (enExample) 1975-07-28
FR2253512B1 (enExample) 1978-02-03

Similar Documents

Publication Publication Date Title
AU476761B2 (enExample)
AU465372B2 (enExample)
AU474593B2 (enExample)
AU474511B2 (enExample)
AU474838B2 (enExample)
FR2253512B1 (enExample)
AU471343B2 (enExample)
AU465453B2 (enExample)
AU465434B2 (enExample)
AU450229B2 (enExample)
AU476714B2 (enExample)
AU472848B2 (enExample)
AU476696B2 (enExample)
AU466283B2 (enExample)
AU477823B2 (enExample)
AU471461B2 (enExample)
AU477824B2 (enExample)
AU476873B1 (enExample)
AU479405A (enExample)
CH562434A5 (enExample)
AU479404A (enExample)
AU479419A (enExample)
AU479539A (enExample)
AU479420A (enExample)
AU479422A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse